Francardo V - Search Results

1

Increased CSF biomarkers of angiogenesis in Parkinson disease.

Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE, van Westen D, Londos E, Cenci MA, Hansson O. Janelidze S, et al. Among authors: francardo v. Neurology. 2015 Nov 24;85(21):1834-42. doi: 10.1212/WNL.0000000000002151. Epub 2015 Oct 28. Neurology. 2015. PMID: 26511451 Free PMC article.

2

Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.

Ohlin KE, Francardo V, Lindgren HS, Sillivan SE, O'Sullivan SS, Luksik AS, Vassoler FM, Lees AJ, Konradi C, Cenci MA. Ohlin KE, et al. Among authors: francardo v. Brain. 2011 Aug;134(Pt 8):2339-57. doi: 10.1093/brain/awr165. Epub 2011 Jul 19. Brain. 2011. PMID: 21771855 Free PMC article.

3

Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease.

Francardo V, Schmitz Y, Sulzer D, Cenci MA. Francardo V, et al. Exp Neurol. 2017 Dec;298(Pt B):137-147. doi: 10.1016/j.expneurol.2017.10.001. Epub 2017 Oct 5. Exp Neurol. 2017. PMID: 28988910 Review.

4

Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse.

Francardo V, Cenci MA. Francardo V, et al. Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S20-2. doi: 10.1016/S1353-8020(13)70008-7. Parkinsonism Relat Disord. 2014. PMID: 24262181 Review.

5

Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.

Francardo V, Bez F, Wieloch T, Nissbrandt H, Ruscher K, Cenci MA. Francardo V, et al. Brain. 2014 Jul;137(Pt 7):1998-2014. doi: 10.1093/brain/awu107. Epub 2014 Apr 22. Brain. 2014. PMID: 24755275

6

Rodent models of impulsive-compulsive behaviors in Parkinson's disease: How far have we reached?

Cenci MA, Francardo V, O'Sullivan SS, Lindgren HS. Cenci MA, et al. Among authors: francardo v. Neurobiol Dis. 2015 Oct;82:561-573. doi: 10.1016/j.nbd.2015.08.026. Epub 2015 Aug 30. Neurobiol Dis. 2015. PMID: 26325219 Review.

7

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA. Francardo V, et al. Neurobiol Dis. 2011 Jun;42(3):327-40. doi: 10.1016/j.nbd.2011.01.024. Epub 2011 Feb 19. Neurobiol Dis. 2011. PMID: 21310234

8

A model of GDNF gene therapy in mice with 6-Hydroxydopamine lesions: time course of Neurorestorative effects and ERK1/2 activation.

Lindgren N, Francardo V, Quintino L, Lundberg C, Cenci MA. Lindgren N, et al. Among authors: francardo v. J Parkinsons Dis. 2012;2(4):333-48. doi: 10.3233/JPD-012146. J Parkinsons Dis. 2012. PMID: 23938263

9

Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion.

Bez F, Francardo V, Cenci MA. Bez F, et al. Among authors: francardo v. Neurobiol Dis. 2016 Oct;94:213-25. doi: 10.1016/j.nbd.2016.06.005. Epub 2016 Jun 14. Neurobiol Dis. 2016. PMID: 27312773

10

Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.

Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, Cenci MA, Svenningsson P, Greengard P, Kaplitt MG. Marongiu R, et al. Among authors: francardo v. Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1423-8. doi: 10.1073/pnas.1524387113. Epub 2016 Jan 19. Proc Natl Acad Sci U S A. 2016. PMID: 26787858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters